Literature DB >> 26238458

Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.

Magdalena Stepien1, Talita Duarte-Salles1, Veronika Fedirko2, Anne Floegel3, Dinesh Kumar Barupal1, Sabina Rinaldi1, David Achaintre1, Nada Assi1, Anne Tjønneland4, Kim Overvad5, Nadia Bastide6,7,8, Marie-Christine Boutron-Ruault6,7,8, Gianluca Severi9, Tilman Kühn10, Rudolf Kaaks10, Krasimira Aleksandrova3, Heiner Boeing3, Antonia Trichopoulou11,12, Christina Bamia11,13, Pagona Lagiou13,14, Calogero Saieva15, Claudia Agnoli16, Salvatore Panico17, Rosario Tumino18, Alessio Naccarati19, H B As Bueno-de-Mesquita20,21,22,23, Petra H Peeters24, Elisabete Weiderpass25,26,27,28, J Ramón Quirós29, Antonio Agudo30, María-José Sánchez31,32, Miren Dorronsoro33, Diana Gavrila32,34,35, Aurelio Barricarte32,36, Bodil Ohlsson37, Klas Sjöberg38,39, Mårten Werner40, Malin Sund41, Nick Wareham42, Kay-Tee Khaw43, Ruth C Travis44, Julie A Schmidt44, Marc Gunter45, Amanda Cross45, Paolo Vineis45, Isabelle Romieu1, Augustin Scalbert1, Mazda Jenab1.   

Abstract

Perturbations in levels of amino acids (AA) and their derivatives are observed in hepatocellular carcinoma (HCC). Yet, it is unclear whether these alterations precede or are a consequence of the disease, nor whether they pertain to anatomically related cancers of the intrahepatic bile duct (IHBC), and gallbladder and extrahepatic biliary tract (GBTC). Circulating standard AA, biogenic amines and hexoses were measured (Biocrates AbsoluteIDQ-p180Kit) in a case-control study nested within a large prospective cohort (147 HCC, 43 IHBC and 134 GBTC cases). Liver function and hepatitis status biomarkers were determined separately. Multivariable conditional logistic regression was used to calculate odds ratios and 95% confidence intervals (OR; 95%CI) for log-transformed standardised (mean = 0, SD = 1) serum metabolite levels and relevant ratios in relation to HCC, IHBC or GBTC risk. Fourteen metabolites were significantly associated with HCC risk, of which seven metabolites and four ratios were the strongest predictors in continuous models. Leucine, lysine, glutamine and the ratio of branched chain to aromatic AA (Fischer's ratio) were inversely, while phenylalanine, tyrosine and their ratio, glutamate, glutamate/glutamine ratio, kynurenine and its ratio to tryptophan were positively associated with HCC risk. Confounding by hepatitis status and liver enzyme levels was observed. For the other cancers no significant associations were observed. In conclusion, imbalances of specific AA and biogenic amines may be involved in HCC development.
© 2015 UICC.

Entities:  

Keywords:  amino acids; biliary tract cancers; hepatocellular carcinoma; prospective cohort; targeted metabolomics

Mesh:

Substances:

Year:  2015        PMID: 26238458     DOI: 10.1002/ijc.29718

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Technical Challenges in Mass Spectrometry-Based Metabolomics.

Authors:  Fumio Matsuda
Journal:  Mass Spectrom (Tokyo)       Date:  2016-11-25

Review 2.  Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists.

Authors:  Eline H van Roekel; Erikka Loftfield; Rachel S Kelly; Oana A Zeleznik; Krista A Zanetti
Journal:  Metabolomics       Date:  2019-01-07       Impact factor: 4.290

3.  Distinct amino acid and lipid perturbations characterize acute versus chronic malaria.

Authors:  Regina Joice Cordy; Rapatbhorn Patrapuvich; Loukia N Lili; Monica Cabrera-Mora; Jung-Ting Chien; Gregory K Tharp; Manoj Khadka; Esmeralda Vs Meyer; Stacey A Lapp; Chester J Joyner; AnaPatricia Garcia; Sophia Banton; ViLinh Tran; Viravarn Luvira; Siriwan Rungin; Teerawat Saeseu; Nattawan Rachaphaew; Suman B Pakala; Jeremy D DeBarry; Jessica C Kissinger; Eric A Ortlund; Steven E Bosinger; John W Barnwell; Dean P Jones; Karan Uppal; Shuzhao Li; Jetsumon Sattabongkot; Alberto Moreno; Mary R Galinski
Journal:  JCI Insight       Date:  2019-05-02

4.  Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort.

Authors:  Nada Assi; Marc J Gunter; Duncan C Thomas; Michael Leitzmann; Magdalena Stepien; Véronique Chajès; Thierry Philip; Paolo Vineis; Christina Bamia; Marie-Christine Boutron-Ruault; Torkjel M Sandanger; Amaia Molinuevo; Hendriek Boshuizen; Anneli Sundkvist; Tilman Kühn; Ruth Travis; Kim Overvad; Elio Riboli; Augustin Scalbert; Mazda Jenab; Vivian Viallon; Pietro Ferrari
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

5.  Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.

Authors:  Nada Assi; Duncan C Thomas; Michael Leitzmann; Magdalena Stepien; Véronique Chajès; Thierry Philip; Paolo Vineis; Christina Bamia; Marie-Christine Boutron-Ruault; Torkjel M Sandanger; Amaia Molinuevo; Hendriek C Boshuizen; Anneli Sundkvist; Tilman Kühn; Ruth C Travis; Kim Overvad; Elio Riboli; Marc J Gunter; Augustin Scalbert; Mazda Jenab; Pietro Ferrari; Vivian Viallon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-21       Impact factor: 4.254

Review 6.  Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids.

Authors:  Joana Krämer; Rui Kang; Laura M Grimm; Luisa De Cola; Pierre Picchetti; Frank Biedermann
Journal:  Chem Rev       Date:  2022-01-07       Impact factor: 60.622

7.  Serum Amino Acid Profiles Predict the Development of Hepatocellular Carcinoma in Patients with Chronic HBV Infection.

Authors:  Tao Wu; Xiaojiao Zheng; Ming Yang; Aihua Zhao; Hongjiao Xiang; Tianlu Chen; Wei Jia; Guang Ji
Journal:  ACS Omega       Date:  2022-04-25

8.  Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Marie Breeur; Pietro Ferrari; Laure Dossus; Mazda Jenab; Mattias Johansson; Sabina Rinaldi; Ruth C Travis; Mathilde His; Tim J Key; Julie A Schmidt; Kim Overvad; Anne Tjønneland; Cecilie Kyrø; Joseph A Rothwell; Nasser Laouali; Gianluca Severi; Rudolf Kaaks; Verena Katzke; Matthias B Schulze; Fabian Eichelmann; Domenico Palli; Sara Grioni; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Bas Bueno-de-Mesquita; Karina Standahl Olsen; Torkjel Manning Sandanger; Therese Haugdahl Nøst; J Ramón Quirós; Catalina Bonet; Miguel Rodríguez Barranco; María-Dolores Chirlaque; Eva Ardanaz; Malte Sandsveden; Jonas Manjer; Linda Vidman; Matilda Rentoft; David Muller; Kostas Tsilidis; Alicia K Heath; Hector Keun; Jerzy Adamski; Pekka Keski-Rahkonen; Augustin Scalbert; Marc J Gunter; Vivian Viallon
Journal:  BMC Med       Date:  2022-10-19       Impact factor: 11.150

9.  Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma.

Authors:  Alexandros P Siskos; Pooja Jain; Werner Römisch-Margl; Mark Bennett; David Achaintre; Yasmin Asad; Luke Marney; Larissa Richardson; Albert Koulman; Julian L Griffin; Florence Raynaud; Augustin Scalbert; Jerzy Adamski; Cornelia Prehn; Hector C Keun
Journal:  Anal Chem       Date:  2016-12-13       Impact factor: 6.986

10.  Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality.

Authors:  Erikka Loftfield; Magdalena Stepien; Vivian Viallon; Laura Trijsburg; Joseph A Rothwell; Nivonirina Robinot; Carine Biessy; Ingvar A Bergdahl; Stina Bodén; Matthias B Schulze; Manuela Bergman; Elisabete Weiderpass; Julie A Schmidt; Raul Zamora-Ros; Therese H Nøst; Torkjel M Sandanger; Emily Sonestedt; Bodil Ohlsson; Verena Katzke; Rudolf Kaaks; Fulvio Ricceri; Anne Tjønneland; Christina C Dahm; Maria-Jose Sánchez; Antonia Trichopoulou; Rosario Tumino; María-Dolores Chirlaque; Giovanna Masala; Eva Ardanaz; Roel Vermeulen; Paul Brennan; Demetrius Albanes; Stephanie J Weinstein; Augustin Scalbert; Neal D Freedman; Marc J Gunter; Mazda Jenab; Rashmi Sinha; Pekka Keski-Rahkonen; Pietro Ferrari
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.